| RS727503904 |
DOLK
|
Health Risk |
Pathogenic |
— |
| RS727503908 |
DYNC2H1
|
Health Risk |
Pathogenic |
— |
| RS727503909 |
DYSF
|
Health Risk |
Pathogenic |
Autosomal recessive limb-girdle muscular dystrophy type 2B, Miyoshi muscular dystrophy 1 |
| RS727503910 |
DYSF
|
Health Risk |
Pathogenic |
Autosomal recessive limb-girdle muscular dystrophy type 2B, Neuromuscular disease caused by qualitative or quantitative defects of dysferlin |
| RS727503911 |
DYSF
|
Health Risk |
Pathogenic |
Autosomal recessive limb-girdle muscular dystrophy type 2B, Neuromuscular disease caused by qualitative or quantitative defects of dysferlin |
| RS727503912 |
DYSF
|
Health Risk |
Pathogenic |
Neuromuscular disease caused by qualitative or quantitative defects of dysferlin, Miyoshi muscular dystrophy 1 |
| RS727503913 |
DYSF
|
Health Risk |
Conflicting classifications of pathogenicity |
Neuromuscular disease caused by qualitative or quantitative defects of dysferlin, Neuromuscular disease caused by qualitative or quantitative defects of dysferlin |
| RS727503915 |
DYSF
|
Health Risk |
Pathogenic/Likely pathogenic |
Neuromuscular disease caused by qualitative or quantitative defects of dysferlin, Autosomal recessive limb-girdle muscular dystrophy |
| RS727503918 |
ETFA
|
Health Risk |
Conflicting classifications of pathogenicity |
Multiple acyl-CoA dehydrogenase deficiency, Multiple acyl-CoA dehydrogenase deficiency |
| RS727503919 |
ETFDH
|
Health Risk |
Pathogenic/Likely pathogenic |
Multiple acyl-CoA dehydrogenase deficiency, Multiple acyl-CoA dehydrogenase deficiency |
| RS727503925 |
FGD1;TSR2
|
Health Risk |
Conflicting classifications of pathogenicity |
TSR2-related disorder, TSR2-related disorder |
| RS727503926 |
FH
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary cancer-predisposing syndrome, Hereditary leiomyomatosis and renal cell cancer |
| RS727503927 |
FH
|
Health Risk |
Pathogenic/Likely pathogenic |
Hereditary leiomyomatosis and renal cell cancer, Hereditary leiomyomatosis and renal cell cancer |
| RS727503928 |
FH
|
Health Risk |
Pathogenic |
— |
| RS727503930 |
FLNA
|
Health Risk |
Conflicting classifications of pathogenicity |
Frontometaphyseal dysplasia, Oto-palato-digital syndrome |
| RS727503931 |
FLNA
|
Health Risk |
Pathogenic |
— |
| RS727503932 |
FOXC1
|
Health Risk |
Conflicting classifications of pathogenicity |
Axenfeld-Rieger syndrome type 3, Axenfeld-Rieger syndrome type 3 |
| RS727503934 |
FOXG1
|
Health Risk |
Pathogenic |
— |
| RS727503935 |
FOXG1
|
Health Risk |
Likely pathogenic |
FOXG1 disorder, Rett syndrome |
| RS727503939 |
GAA
|
Health Risk |
Conflicting classifications of pathogenicity |
Glycogen storage disease, type II |
| RS727503940 |
GABRA1
|
Health Risk |
Pathogenic/Likely pathogenic |
Epilepsy, idiopathic generalized |
| RS727503941 |
GABRG2
|
Health Risk |
Conflicting classifications of pathogenicity |
Inborn genetic diseases, Febrile seizures |
| RS727503943 |
GALE
|
Health Risk |
Conflicting classifications of pathogenicity |
UDPglucose-4-epimerase deficiency, UDPglucose-4-epimerase deficiency |
| RS727503946 |
GALNS
|
Health Risk |
Pathogenic/Likely pathogenic |
Mucopolysaccharidosis, MPS-IV-A |
| RS727503947 |
GALT
|
Health Risk |
Conflicting classifications of pathogenicity |
Deficiency of UDPglucose-hexose-1-phosphate uridylyltransferase, Deficiency of UDPglucose-hexose-1-phosphate uridylyltransferase |
| RS727503948 |
GLA
|
Health Risk |
Conflicting classifications of pathogenicity |
Fabry disease, Fabry disease |
| RS727503949 |
GLA
|
Health Risk |
Pathogenic |
Fabry disease, Cardiovascular phenotype |
| RS727503950 |
GLA
|
Health Risk |
Conflicting classifications of pathogenicity |
Fabry disease, Migalastat response |
| RS727503951 |
GLA
|
Health Risk |
Conflicting classifications of pathogenicity |
Fabry disease, Fabry disease |
| RS727503952 |
GLB1
|
Health Risk |
Pathogenic |
GM1 gangliosidosis, Mucopolysaccharidosis |
| RS727503954 |
GLB1
|
Health Risk |
Likely pathogenic |
— |
| RS727503955 |
ADGRG1
|
Health Risk |
Conflicting classifications of pathogenicity |
— |
| RS727503958 |
HCN4
|
Health Risk |
Conflicting classifications of pathogenicity |
Cardiovascular phenotype, Brugada syndrome 8 |
| RS727503959 |
HEXB
|
Health Risk |
Conflicting classifications of pathogenicity |
Sandhoff disease, Sandhoff disease |
| RS727503961 |
HEXB
|
Health Risk |
Conflicting classifications of pathogenicity |
Sandhoff disease, Sandhoff disease |
| RS727503962 |
HGSNAT
|
Health Risk |
Conflicting classifications of pathogenicity |
Mucopolysaccharidosis, MPS-III-C |
| RS727503963 |
HMGCL
|
Health Risk |
Pathogenic/Likely pathogenic |
Deficiency of hydroxymethylglutaryl-CoA lyase, Long chain 3-hydroxyacyl-CoA dehydrogenase deficiency |
| RS727503964 |
HPRT1
|
Health Risk |
Pathogenic |
— |
| RS727503966 |
IDUA
|
Health Risk |
Pathogenic |
Hurler syndrome, Mucopolysaccharidosis type 1 |
| RS727503967 |
IDUA
|
Health Risk |
Pathogenic |
Hurler syndrome, Mucopolysaccharidosis type 1 |
| RS727503968 |
IQCB1
|
Health Risk |
Pathogenic |
Nephronophthisis, Senior-Loken syndrome 5 |
| RS727503969 |
IQCB1
|
Health Risk |
Pathogenic |
Nephronophthisis, Senior-Loken syndrome 5 |
| RS727503970 |
IVD
|
Health Risk |
Conflicting classifications of pathogenicity |
Inborn genetic diseases, Inborn genetic diseases |
| RS727503973 |
KCNQ2
|
Health Risk |
Conflicting classifications of pathogenicity |
— |
| RS727503974 |
KCNQ2
|
Health Risk |
Pathogenic/Likely pathogenic |
Developmental and epileptic encephalopathy, 7 |
| RS727503976 |
KDM6A
|
Health Risk |
Conflicting classifications of pathogenicity |
Kabuki syndrome 2, Kabuki syndrome 2 |
| RS727503977 |
NEXMIF
|
Health Risk |
Pathogenic |
X-linked intellectual disability, Cantagrel type |
| RS727503979 |
KMT2D
|
Health Risk |
Pathogenic |
Kabuki syndrome 1, Kabuki syndrome |
| RS727503980 |
KMT2D
|
Health Risk |
Conflicting classifications of pathogenicity |
Kabuki syndrome, KMT2D-related disorder |
| RS727503981 |
KMT2D
|
Health Risk |
Conflicting classifications of pathogenicity |
KMT2D-related disorder, Kabuki syndrome |
| RS727503982 |
KMT2D
|
Health Risk |
Conflicting classifications of pathogenicity |
Kabuki syndrome 1, Choanal atresia-athelia-hypothyroidism-delayed puberty-short stature syndrome |
| RS727503983 |
KMT2D
|
Health Risk |
Pathogenic |
Kabuki syndrome, Kabuki syndrome 1 |
| RS727503985 |
KMT2D
|
Health Risk |
Conflicting classifications of pathogenicity |
Kabuki syndrome, KMT2D-related disorder |
| RS727503986 |
KMT2D
|
Health Risk |
Pathogenic |
— |
| RS727503987 |
KMT2D
|
Health Risk |
Pathogenic |
Kabuki syndrome 1, Kabuki syndrome |
| RS727503988 |
KMT2D
|
Health Risk |
Pathogenic |
— |
| RS727503989 |
KMT2D
|
Health Risk |
Pathogenic |
— |
| RS727503990 |
KMT2D
|
Health Risk |
Pathogenic |
— |
| RS727503992 |
LAMA2
|
Health Risk |
Pathogenic/Likely pathogenic |
Merosin deficient congenital muscular dystrophy, LAMA2-related muscular dystrophy |
| RS727503994 |
LARGE1
|
Health Risk |
Conflicting classifications of pathogenicity |
Muscular dystrophy-dystroglycanopathy type B6, Muscular dystrophy-dystroglycanopathy type B6 |
| RS727503996 |
MAP2K1
|
Health Risk |
Pathogenic |
Noonan syndrome, RASopathy |
| RS727503997 |
MBD5
|
Health Risk |
Conflicting classifications of pathogenicity |
Intellectual disability, autosomal dominant 1 |
| RS727503999 |
MBD5
|
Health Risk |
Conflicting classifications of pathogenicity |
Intellectual disability, autosomal dominant 1 |
| RS727504000 |
MBD5
|
Health Risk |
Conflicting classifications of pathogenicity |
Intellectual disability, autosomal dominant 1 |
| RS727504001 |
MCCC1
|
Health Risk |
Pathogenic/Likely pathogenic |
3-methylcrotonyl-CoA carboxylase 1 deficiency, Methylcrotonyl-CoA carboxylase deficiency |
| RS727504002 |
MCCC1
|
Health Risk |
Pathogenic |
3-methylcrotonyl-CoA carboxylase 1 deficiency, Methylcrotonyl-CoA carboxylase deficiency |
| RS727504004 |
MCCC1
|
Health Risk |
Conflicting classifications of pathogenicity |
3-methylcrotonyl-CoA carboxylase 1 deficiency, MCCC1-related disorder |
| RS727504005 |
MCCC1
|
Health Risk |
Pathogenic/Likely pathogenic |
3-methylcrotonyl-CoA carboxylase 1 deficiency, MCCC1-related disorder |
| RS727504006 |
MCCC1
|
Health Risk |
Pathogenic/Likely pathogenic |
3-methylcrotonyl-CoA carboxylase 1 deficiency, 3-methylcrotonyl-CoA carboxylase 1 deficiency |
| RS727504009 |
MCCC2
|
Health Risk |
Conflicting classifications of pathogenicity |
3-methylcrotonyl-CoA carboxylase 2 deficiency, MCCC2-related disorder |
| RS727504010 |
MCCC2
|
Health Risk |
Pathogenic/Likely pathogenic |
3-methylcrotonyl-CoA carboxylase 2 deficiency, 3-methylcrotonyl-CoA carboxylase 2 deficiency |
| RS727504011 |
MCCC2
|
Health Risk |
Conflicting classifications of pathogenicity |
3-methylcrotonyl-CoA carboxylase 2 deficiency, 3-methylcrotonyl-CoA carboxylase 2 deficiency |
| RS727504012 |
MCPH1
|
Health Risk |
Conflicting classifications of pathogenicity |
— |
| RS727504015 |
MID1
|
Health Risk |
Conflicting classifications of pathogenicity |
— |
| RS727504020 |
MMUT
|
Health Risk |
Likely pathogenic |
Methylmalonic aciduria due to methylmalonyl-CoA mutase deficiency, Methylmalonic aciduria due to complete methylmalonyl-CoA mutase deficiency |
| RS727504022 |
MMUT
|
Health Risk |
Pathogenic/Likely pathogenic |
Methylmalonic aciduria due to methylmalonyl-CoA mutase deficiency, Methylmalonic aciduria due to complete methylmalonyl-CoA mutase deficiency |
| RS727504023 |
MYO7A
|
Health Risk |
Conflicting classifications of pathogenicity |
— |
| RS727504024 |
MYO7A
|
Health Risk |
Conflicting classifications of pathogenicity |
Autosomal dominant nonsyndromic hearing loss 11, Autosomal recessive nonsyndromic hearing loss 2 |
| RS727504026 |
MYOT
|
Health Risk |
Conflicting classifications of pathogenicity |
Myofibrillar myopathy 3, Inborn genetic diseases |
| RS727504028 |
NAGLU
|
Health Risk |
Pathogenic |
Mucopolysaccharidosis, MPS-III-B |
| RS727504031 |
NDP
|
Health Risk |
Pathogenic |
Atrophia bulborum hereditaria, Atrophia bulborum hereditaria |
| RS727504033 |
NEB
|
Health Risk |
Conflicting classifications of pathogenicity |
Nemaline myopathy 2, Nemaline myopathy 2 |
| RS727504037 |
NEB
|
Health Risk |
Conflicting classifications of pathogenicity |
Nemaline myopathy 2, Inborn genetic diseases |
| RS727504039 |
NHS
|
Health Risk |
Conflicting classifications of pathogenicity |
Nance-Horan syndrome, Cataract 40 |
| RS727504040 |
NHS
|
Health Risk |
Pathogenic |
— |
| RS727504042 |
NHS
|
Health Risk |
Conflicting classifications of pathogenicity |
Nance-Horan syndrome, Nance-Horan syndrome |
| RS727504044 |
NHS
|
Health Risk |
Pathogenic |
— |
| RS727504046 |
NIPBL
|
Health Risk |
Conflicting classifications of pathogenicity |
Cornelia de Lange syndrome 1, Cornelia de Lange syndrome 1 |
| RS727504047 |
NIPBL
|
Health Risk |
Pathogenic |
— |
| RS727504053 |
NSD1
|
Health Risk |
Conflicting classifications of pathogenicity |
— |
| RS727504054 |
NSD1
|
Health Risk |
Conflicting classifications of pathogenicity |
— |
| RS727504058 |
OPA1
|
Health Risk |
Pathogenic |
— |
| RS727504059 |
OPA1
|
Health Risk |
Pathogenic |
Ocular impairment, Ocular impairment |
| RS727504060 |
OPA1
|
Health Risk |
Pathogenic |
Optic atrophy, Optic atrophy |
| RS727504062 |
OPHN1
|
Health Risk |
Conflicting classifications of pathogenicity |
— |
| RS727504064 |
PAX6
|
Health Risk |
Conflicting classifications of pathogenicity |
Anophthalmia-microphthalmia syndrome, Anophthalmia-microphthalmia syndrome |
| RS727504067 |
PCDH19
|
Health Risk |
Conflicting classifications of pathogenicity |
Developmental and epileptic encephalopathy, 9 |
| RS727504069 |
PCDH15
|
Health Risk |
Conflicting classifications of pathogenicity |
PCDH15-related disorder, PCDH15-related disorder |
| RS727504070 |
PCDH15
|
Health Risk |
Conflicting classifications of pathogenicity |
— |
| RS727504072 |
PDE6A
|
Health Risk |
Conflicting classifications of pathogenicity |
— |